Akoya Biosciences, Inc. (AKYA)
NASDAQ: AKYA · Real-Time Price · USD
1.240
-0.090 (-6.77%)
Jun 27, 2025, 4:00 PM - Market closed
Akoya Biosciences Stock Forecast
Stock Price Forecast
The 7 analysts that cover Akoya Biosciences stock have a consensus rating of "Hold" and an average price target of $2.51, which forecasts a 102.42% increase in the stock price over the next year. The lowest target is $1.08 and the highest is $5.
Price Target: $2.51 (+102.42%)
Analyst Consensus: Hold
* Price targets were last updated on May 19, 2025.
Analyst Ratings
The average analyst rating for Akoya Biosciences stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 | Jun '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 1 | 0 | 0 | 0 |
| Buy | 1 | 1 | 1 | 0 | 0 | 0 |
| Hold | 5 | 5 | 5 | 7 | 7 | 7 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 8 | 8 | 7 | 7 | 7 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Canaccord Genuity | Canaccord Genuity | Hold Maintains $1.8 → $1.08 | Hold | Maintains | $1.8 → $1.08 | -12.90% | May 19, 2025 |
| Canaccord Genuity | Canaccord Genuity | Hold Maintains $3.5 → $1.8 | Hold | Maintains | $3.5 → $1.8 | +45.16% | Apr 29, 2025 |
| Piper Sandler | Piper Sandler | Hold Maintains $2.4 → $1.65 | Hold | Maintains | $2.4 → $1.65 | +33.06% | Apr 14, 2025 |
| Stephens & Co. | Stephens & Co. | Buy → Hold Downgrades $3.5 → $1.8 | Buy → Hold | Downgrades | $3.5 → $1.8 | +45.16% | Mar 25, 2025 |
| Stephens & Co. | Stephens & Co. | Buy Reiterates $3.5 | Buy | Reiterates | $3.5 | +182.26% | Mar 18, 2025 |
Financial Forecast
Revenue This Year
87.60M
from 81.67M
Increased by 7.26%
Revenue Next Year
97.62M
from 87.60M
Increased by 11.44%
EPS This Year
-0.76
from -1.12
EPS Next Year
-0.60
from -0.76
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 97.7M | 110.3M | 125.1M | ||
| Avg | 87.6M | 97.6M | 108.8M | ||
| Low | 76.0M | 89.1M | 95.4M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 19.6% | 25.9% | 28.1% | ||
| Avg | 7.3% | 11.4% | 11.4% | ||
| Low | -7.0% | 1.7% | -2.3% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -0.46 | -0.36 | -0.40 | ||
| Avg | -0.76 | -0.60 | -0.47 | ||
| Low | -0.90 | -0.67 | -0.49 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.